Horizon Kinetics Asset Management LLC Royalty Pharma PLC Transaction History
Horizon Kinetics Asset Management LLC
- $7.14 Billion
- Q4 2024
A detailed history of Horizon Kinetics Asset Management LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Horizon Kinetics Asset Management LLC holds 319,176 shares of RPRX stock, worth $10.6 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
319,176
Previous 228,796
39.5%
Holding current value
$10.6 Million
Previous $6.47 Million
25.8%
% of portfolio
0.11%
Previous 0.11%
Shares
16 transactions
Others Institutions Holding RPRX
# of Institutions
431Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.32 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.24 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$767 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$565 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$471 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.6B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...